News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mack Anthony P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/07/2023 |
4/A
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $0.867, valued at
$108.4k
|
|
| 01/27/2023 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $0.788, valued at
$98.5k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/02/2022 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $2.34, valued at
$351k
|
|
| 11/22/2021 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 25,125 shares
@ $3.99, valued at
$100.2k
|
|
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|